Defining conversion therapy for esophageal squamous cell carcinoma

被引:14
|
作者
Matsuda, Satoru [1 ]
Tsushima, Takahiro [2 ]
Kato, Ken [3 ]
Hsu, Chih-Hung [4 ]
Lee, Jang Ming [5 ]
Wong, Ian Yu-Hong [6 ]
Wang, Hu-Lin Christina [7 ]
Kang, Chang Hyun [8 ]
Guo, Xufeng [9 ]
Yamamoto, Shun [3 ]
Tsuji, Takayuki [1 ]
Kawakubo, Hirofumi [1 ]
Takeuchi, Hiroya [10 ]
Law, Simon [6 ]
Kitagawa, Yuko [1 ]
机构
[1] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan
[2] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[3] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
[4] Natl Taiwan Univ Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan
[6] Univ Hong Kong, Sch Clin Med, Dept Surg, Hong Kong, Peoples R China
[7] Far Eastern Mem Hosp, Div Traumatol, Taipei, Taiwan
[8] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[9] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[10] Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka, Japan
来源
关键词
conversion surgery; conversion therapy; esophageal squamous cell carcinoma; CHEMOTHERAPY; CANCER;
D O I
10.1002/ags3.12623
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant metastasis.
引用
收藏
页码:7 / 9
页数:3
相关论文
共 50 条
  • [21] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Wing-Lok Chan
    Cheuk-Wai Choi
    Ian Yu-Hong Wong
    Terence Hon-Ting Tsang
    Adrian Tin-Chung Lam
    Rosa Pui-Ying Tse
    K. K. Chan
    Claudia Wong
    Betty Tze-Ting Law
    Emina Edith Cheung
    Siu-Yin Chan
    Ka-On Lam
    Dora Kwong
    Simon Law
    Annals of Surgical Oncology, 2023, 30 : 861 - 870
  • [22] The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma
    Akutsu, Yasunori
    Qin, Wei
    Murakami, Kentaro
    Hoshino, Isamu
    Hanari, Naoyuki
    Nishimori, Takanori
    Mori, Mikito
    Isozaki, Yuka
    Toyozumi, Takeshi
    Hu, Xin
    Suito, Hiroshi
    Akanuma, Naoki
    Takahashi, Masahiko
    Matsubara, Hisahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [23] Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy
    Yanagita, Takumi
    Hikichi, Takuto
    Nakamura, Jun
    Hashimoto, Minami
    Kato, Tsunetaka
    Suzuki, Rei
    Sugimoto, Mitsuru
    Sato, Yuki
    Irie, Hiroki
    Takagi, Tadayuki
    Kobayakawa, Masao
    Ohira, Hiromasa
    LIFE-BASEL, 2023, 13 (06):
  • [24] Glypican-1 as a Therapy Target in Esophageal Squamous Cell Carcinoma
    Qingcui Song
    Digestive Diseases and Sciences, 2019, 64 : 3355 - 3356
  • [25] Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
    Doki, Y.
    Ajani, J. A.
    Kato, K.
    Xu, J.
    Wyrwicz, L.
    Motoyama, S.
    Ogata, T.
    Kawakami, H.
    Hsu, C. -H.
    Adenis, A.
    El Hajbi, F.
    Di Bartolomeo, M.
    Braghiroli, M. I.
    Holtved, E.
    Ostoich, S. A.
    Kim, H. R.
    Ueno, M.
    Mansoor, W.
    Yang, W. -C.
    Liu, T.
    Bridgewater, J.
    Makino, T.
    Xynos, I.
    Liu, X.
    Lei, M.
    Kondo, K.
    Patel, A.
    Gricar, J.
    Chau, I.
    Kitagawa, Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05): : 449 - 462
  • [26] Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis
    Boone, J.
    van Hillegersberg, R.
    Offerhaus, G. J. A.
    van Diest, P. J.
    Rinkes, I. H. M. Borel
    ten Kate, F. J. W.
    DISEASES OF THE ESOPHAGUS, 2009, 22 (06) : 496 - 504
  • [27] Factors Predicting Effectiveness of Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
    Ohkura, Yu
    Ueno, Masaki
    Iizuka, Toshiro
    Haruta, Shusuke
    Tanaka, Tsuyoshi
    Udagawa, Harushi
    MEDICINE, 2016, 95 (15)
  • [28] Glypican-1 as a Therapy Target in Esophageal Squamous Cell Carcinoma
    Song, Qingcui
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (11) : 3355 - 3356
  • [29] The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
    Shiraishi, Kazuhiro
    Okada, Mao
    Yamamoto, Shun
    Matsubara, Yuki
    Masuishi, Toshiki
    Shimozaki, Keitaro
    Yamamoto, Yoshiyuki
    Hirose, Suguru
    Sugiyama, Keiji
    Furuta, Mitsuhiro
    Machida, Nozomu
    Takahashi, Naoki
    Yoshii, Takako
    Kito, Yosuke
    Tsuzuki, Takao
    Boku, Shogen
    Tsuchihashi, Kenji
    Sugaya, Akinori
    Takayama, Toshizo
    Komori, Azusa
    Mitani, Seiichiro
    Matsumoto, Toshihiko
    Nishimura, Takashi
    Hirata, Kenro
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [30] NOVEL PHOTODYNAMIC THERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA FOLLOWING RADIOTHERAPY
    Yanagita, Takumi
    Hikichi, Takuto
    Nakamura, Jun
    Hashimoto, Minami
    Kato, Tsunetaka
    Suzuki, Rei
    Sugimoto, Mitsuru
    Asama, Hiroyuki
    Sato, Yuki
    Takagi, Tadayuki
    Kobayakawa, Masao
    Ohira, Hiromasa
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB1053 - AB1054